CORC

在结果中检索

CORC

浏览/检索结果: 共72条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：16/0  |  提交时间：2023/01/23
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：29/0  |  提交时间：2022/12/30
Class forge: Boosting feature encoder for few-shot learning with synthesized classes 会议论文
Shenzhen, China, July 5-9, 2021
作者:  Rui-Qi Wang;  Xu-Yao Zhang;  Cheng-Lin Liu
收藏  |  浏览/下载：3/0  |  提交时间：2022/04/07
GSS: Graph-based subspace learning with shots initialization for few-shot recognition 会议论文
Shenzhen, China, July 5-9, 2021
作者:  Rui-Qi Wang;  Xu-Yao Zhang;  Cheng-Lin Liu
收藏  |  浏览/下载：4/0  |  提交时间：2022/04/07
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Numerical modelling of fluid transportation based on digital core model 会议论文
2nd International Conference on Physics, Mathematics and Statistics, ICPMS 2019, Hangzhou, China, May 22, 2019 - May 24, 2019
作者:  Liu, Jianjun;  Wang, Rui;  Zhang, Bohu;  Zu, Lin;  He, Xiang
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/27

©版权所有 ©2017 CSpace - Powered by CSpace